ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S has a total of 19 patent applications. Its first patent ever was published in 2009. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and macromolecular chemistry and polymers are ASCENDIS PHARMA BONE DISEASES AS, CONARIS RES INSTITUTE AG and SCICLONE PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | United States | 5 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Canada | 2 | |
#5 | Brazil | 1 | |
#6 | Hungary | 1 | |
#7 | Mexico | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Macromolecular chemistry and polymers | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Special macromolecular compounds | |
#5 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Rau Harald | 16 |
#2 | Wegge Thomas | 16 |
#3 | Lessmann Torben | 11 |
#4 | Kindermann Susanne | 10 |
#5 | Rasmussen Grethe Nørskov | 9 |
#6 | Schubert Nina | 6 |
#7 | Zettler Joachim | 6 |
#8 | Kurpiers Thomas | 6 |
#9 | Hermann Alina | 6 |
#10 | Jensen Steen | 6 |
Publication | Filing date | Title |
---|---|---|
WO2020178273A1 | Long-acting growth hormone dosage forms with superior efficacy to daily somatropin | |
AU2015348633A1 | Novel polymeric hGH prodrugs | |
AU2014200350A1 | Pegylated recombinant human growth hormone compounds |